Activity of sulfa drugs and dihydrofolate reductase inhibitors againstCandida albicans
- 1 April 1982
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 38 (4) , 436-437
- https://doi.org/10.1007/bf01952625
Abstract
Growth ofCandida albicans can be inhibited by sulfa drugs which prevent biosynthesis of folic acid. The dihydrofolate reductase (E.C. 1.5.1.3) inhibitors aminopterin and methotrexate also exhibit anticandidal activity, but trimethoprim does not. Kinetic evaluations withC. albicans dihydrofolate reductase indicate that methotrexate and aminopterin are tight-binding inhibitors whereas trimethoprim binds poorly.This publication has 9 references indexed in Scilit:
- Action of imidazole-containing antifungal drugsLife Sciences, 1981
- Tetroxoprim - a new inhibitor of bacterial dihydrofolate reductaseJournal of Antimicrobial Chemotherapy, 1979
- Inhibition by sulfanilamide of sporulation in Saccharomyces cerevisiaeCanadian Journal of Microbiology, 1977
- Potentiation of the Antifungal Effects of Antibiotics by Amphotericin BAntimicrobial Agents and Chemotherapy, 1972
- INHIBITOR BINDING ANALYSIS OF DIHYDROFOLATE REDUCTASES FROM VARIOUS SPECIES1965
- [48] Dihydrofolic reductasePublished by Elsevier ,1963
- DIFFERENTIAL REVERSAL OF INHIBITORY EFFECTS OF FOLIC ACID ANALOGUES ON GROWTH, DIVISION, AND DEOXYRIBONUCLEIC ACID SYNTHESIS OF MICROORGANISMSJournal of Bacteriology, 1956